Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

770
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
770
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

475
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
475

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urine sodium concentration and diuretic responsiveness in dogs receiving orally administered loop diuretics for chronic congestive heart failure.

Journal of veterinary internal medicine·2026
Same author

Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease.

Journal of veterinary internal medicine·2026
Same author

Serotonin transporter downregulation is associated with aortic stenosis, and early profibrotic remodeling is mitigated by pharmacological inhibition of HTR2B receptor.

Frontiers in cardiovascular medicine·2026
Same author

Plasma Cardiac Troponin-I Concentration in Normal Horses and in Horses with Cardiac Abnormalities.

Animals : an open access journal from MDPI·2025
Same author

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy.

ESC heart failure·2024
Same author

Observed and expected reliability of echocardiographic volumetric methods and critical change values for quantification of mitral regurgitant fraction in dogs.

Journal of veterinary internal medicine·2024

Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.7K

Using Cardiac Biomarkers in Veterinary Practice.

Mark A Oyama1

  • 1Section of Cardiology, Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, 3900 Delancey Street, Philadelphia, PA 19104, USA.

Clinics in Laboratory Medicine
|August 23, 2015
PubMed
Summary
This summary is machine-generated.

Cardiac biomarker testing aids in diagnosing heart disease in pets. Assays like cardiac troponin-I and N-terminal pro-B-type natriuretic peptide help identify disease and assess patient risk.

Keywords:
BNPCardiac biomarkersHeart diseaseNatriuretic peptideTroponin

More Related Videos

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases
10:53

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases

Published on: June 16, 2022

10.5K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

Related Experiment Videos

Last Updated: Apr 5, 2026

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.7K
Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases
10:53

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases

Published on: June 16, 2022

10.5K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.3K

Area of Science:

  • Veterinary Cardiology
  • Clinical Pathology

Background:

  • Blood-based cardiac biomarker assays are valuable tools in veterinary medicine.
  • Cardiac troponin-I and N-terminal pro-B-type natriuretic peptide are key biomarkers for assessing cardiac health in animals.

Purpose of the Study:

  • To review the utility of cardiac biomarker testing in canine and feline cardiology.
  • To highlight the role of biomarkers in diagnosing heart disease, differentiating causes of respiratory distress, and detecting preclinical conditions.

Main Methods:

  • Review of current scientific literature on cardiac biomarker assays in veterinary medicine.
  • Analysis of the application of cardiac troponin-I and N-terminal pro-B-type natriuretic peptide testing in clinical practice.

Main Results:

  • Cardiac biomarker testing aids in differentiating cardiac from non-cardiac causes of respiratory signs.
  • Biomarker assays facilitate the early detection of preclinical cardiomyopathy.
  • Testing can help evaluate the risk of morbidity and mortality in animals with heart disease.

Conclusions:

  • Cardiac biomarker testing is an increasingly important diagnostic and prognostic tool in veterinary cardiology.
  • Effective use requires proper patient selection, accurate result interpretation, and integration into diagnostic workflows.